English

DURAMED PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2001-08-14

37 filing records in this dataset, filed from 1995-05-22 to 2001-08-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

32.5 million USD

2001-06-30 · USD

Exact inputs and evidence

Revenue: 32507622 USD Source

Operating margin

14.22%

2001-06-30 · %

Exact inputs and evidence

Operating Income: 4622295 USD Source
Revenue: 32507622 USD Source

Operating cash flow

-4.04 million USD

2001-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -207790 USD Source
Operating Cash Flow: 3829798 USD Source

Free cash flow

-4.59 million USD

2001-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -207790 USD Source
Operating Cash Flow: 3829798 USD Source
Capital Expenditure: 1376400 USD Source
Capital Expenditure: 820980 USD Source

Cash and cash equivalents: 4 thousand USD 2001-06-30 Source
Exact value

4000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

106 million USD

2000-07-01 – 2001-06-30

Exact inputs and evidence

Revenue: 22444636 USD · 2000-07-01 – 2000-09-30 Source
Revenue: 83465371 USD · 2000-01-01 – 2000-12-31 Source
Revenue: 59705532 USD · 2000-01-01 – 2000-09-30 Source
Revenue: 27323586 USD · 2001-01-01 – 2001-03-31 Source
Revenue: 32507622 USD · 2001-04-01 – 2001-06-30 Source

Net income

8.32 million USD

2000-07-01 – 2001-06-30

Exact inputs and evidence

Net income: 1177742 USD · 2000-07-01 – 2000-09-30 Source
Net income: 676437 USD · 2000-01-01 – 2000-12-31 Source
Net income: -1164375 USD · 2000-01-01 – 2000-09-30 Source
Net income: 1817278 USD · 2001-01-01 – 2001-03-31 Source
Net income: 3484696 USD · 2001-04-01 – 2001-06-30 Source

Operating cash flow

-1.67 million USD

2000-07-01 – 2001-06-30

Exact inputs and evidence

Operating cash flow: -15200673 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -15374696 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: -16840184 USD · 2000-01-01 – 2000-12-31 Source
Operating cash flow: -15200673 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: 3829798 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -207790 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: 3829798 USD · 2001-01-01 – 2001-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2001-08-14.

Financial data available through: 2000-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2000-12-31
Operating income: 8 of 11 periods available· newest 2000-12-31
Net income: 8 of 11 periods available· newest 2000-12-31
Operating cash flow: 8 of 11 periods available· newest 2000-12-31
Capital expenditure: 8 of 11 periods available· newest 2000-12-31
Total assets: 7 of 11 periods available· newest 2000-12-31
Total liabilities: 7 of 11 periods available· newest 2000-12-31
Current assets: 7 of 11 periods available· newest 2000-12-31
Current liabilities: 7 of 11 periods available· newest 2000-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2000-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+66.2%

Prior period

USD 50.22 million

1999-01-01 – 1999-12-31
Current period

USD 83.47 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

83465371 − 50219878 = 33245493 USD

50219878 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
83465371 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · DURAMED PHARMACEUTICALS INC · 2000-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Year-over-year change in Revenue: 33245493 USD Concept: fundies:Revenue Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 83465371 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2225 Input fundies:Revenue: 50219878 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2225
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 51.7 million

Prior period

−USD 51.02 million

1999-01-01 – 1999-12-31
Current period

USD 676,437

2000-01-01 – 2000-12-31

Exact inputs and evidence

676437 − -51022524 = 51698961 USD

-51022524 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
676437 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · DURAMED PHARMACEUTICALS INC · 2000-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Year-over-year change in Net income: 51698961 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 676437 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2349 Input fundies:NetIncome: -51022524 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2349
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 17.84 million

Prior period

−USD 34.68 million

1999-01-01 – 1999-12-31
Current period

−USD 16.84 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-16840184 − -34678044 = 17837860 USD

-34678044 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-16840184 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · DURAMED PHARMACEUTICALS INC · 2000-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Year-over-year change in Operating cash flow: 17837860 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -16840184 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2366 Input fundies:OperatingCashFlow: -34678044 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2366
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-71.5%

Prior period

USD 5.39 million

1999-01-01 – 1999-12-31
Current period

USD 1.53 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

1532188 − 5385363 = -3853175 USD

5385363 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
1532188 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · DURAMED PHARMACEUTICALS INC · 2000-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Year-over-year change in Capital expenditure: -3853175 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1532188 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2370 Input fundies:CapitalExpenditure: 5385363 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2370
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2000 2000-01-01 – 2000-12-31

Revenue USD 83.47 million 100% of revenue
Cost of revenue USD 48.39 million 58% of revenue
Operating expenses USD 29.06 million 35% of revenue
Operating income USD 6.01 million 7.2% of revenue
Tax, interest and other Derived USD 5.33 million 6.4% of revenue
Net income USD 676,437 0.8% of revenue

Cash

Operating cash flow −USD 16.84 million −20% of revenue
Capital expenditure USD 1.53 million 1.8% of revenue
Free cash flow Derived −USD 18.37 million −22% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1993 89%
1994 Net income was higher than operating income, so the split is not drawn.
1995 Net loss: net income was −2% of revenue.
1996 Operating loss: operating costs were 143% of revenue.
1997 Operating loss: operating costs were 136% of revenue.
1998 Operating loss: operating costs were 112% of revenue.
1999 Operating loss: operating costs were 195% of revenue.
2000 93%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1993 1993-01-01 – 1993-12-31	30293239	26934456 Derived	3358783	2143697 Derived	1215086	-165214 Derived	Source 1993-01-01 – 1993-12-31: 30293239 USD Inspect Revenue Open source 1993-01-01 – 1993-12-31: 3358783 USD Inspect Operating Income Open source 1993-01-01 – 1993-12-31: 1215086 USD Inspect Net Income Open source 1993-01-01 – 1993-12-31: 980463 USD Inspect Operating Cash Flow Open source 1993-01-01 – 1993-12-31: 1145677 USD Inspect Capital Expenditure Open source
1994 1994-01-01 – 1994-12-31	45274362	37259343 Derived	8015019	-1535848 Derived	9550867	-2908938 Derived	Source 1994-01-01 – 1994-12-31: 45274362 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: 8015019 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: 9550867 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: 3256646 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 6165584 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	49623526	47889881 Derived	1733645	2724593 Derived	-990948	-11272066 Derived	Source 1995-01-01 – 1995-12-31: 49623526 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: 1733645 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -990948 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -6023456 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 5248610 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	43855014	62814604 Derived	-18959590	5751446 Derived	-24711036	-17056517 Derived	Source 1996-01-01 – 1996-12-31: 43855014 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -18959590 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -24711036 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -11812211 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 5244306 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	44296444	60338646 Derived	-16042202	1399114 Derived	-17441316	-15823950 Derived	Source 1997-01-01 – 1997-12-31: 44296444 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -16042202 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -17441316 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -14350292 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 1473658 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	49759285	55796370 Derived	-6037085	2359408 Derived	-8396493	-17459619 Derived	Source 1998-01-01 – 1998-12-31: 49759285 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -6037085 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -8396493 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -16147921 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 1311698 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	50219878	97690543 Derived	-47470665	3551859 Derived	-51022524	-40063407 Derived	Source 1999-01-01 – 1999-12-31: 50219878 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -47470665 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -51022524 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -34678044 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 5385363 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	83465371	77456644 Derived	6008727	5332290 Derived	676437	-18372372 Derived	Source 2000-01-01 – 2000-12-31: 83465371 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: 6008727 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: 676437 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -16840184 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 1532188 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 83.5M 2000

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Revenue	30293239	Revenue: 30293239 Open source
19941994-12-31	Revenue	45274362	Revenue: 45274362 Open source
19951995-12-31	Revenue	49623526	Revenue: 49623526 Open source
19961996-12-31	Revenue	43855014	Revenue: 43855014 Open source
19971997-12-31	Revenue	44296444	Revenue: 44296444 Open source
19981998-12-31	Revenue	49759285	Revenue: 49759285 Open source
19991999-12-31	Revenue	50219878	Revenue: 50219878 Open source
20002000-12-31	Revenue	83465371	Revenue: 83465371 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

66.2% 2000

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19931993-12-31	Year over year	No prior comparable period	Revenue: 30293239 Open source
19941994-12-31	Year over year	49.5%	Revenue: 45274362 Open source Revenue: 30293239 Open source
19951995-12-31	Year over year	9.6%	Revenue: 49623526 Open source Revenue: 45274362 Open source
19961996-12-31	Year over year	-11.6%	Revenue: 43855014 Open source Revenue: 49623526 Open source
19971997-12-31	Year over year	1%	Revenue: 44296444 Open source Revenue: 43855014 Open source
19981998-12-31	Year over year	12.3%	Revenue: 49759285 Open source Revenue: 44296444 Open source
19991999-12-31	Year over year	0.9%	Revenue: 50219878 Open source Revenue: 49759285 Open source
20002000-12-31	Year over year	66.2%	Revenue: 83465371 Open source Revenue: 50219878 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 7.2% 2000

Net margin 0.8% 2000

Free cash flow margin -22% 2000

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19931993-12-31	Operating margin	11.1%	Operating Income: 3358783 Open source Revenue: 30293239 Open source
19941994-12-31	Operating margin	17.7%	Operating Income: 8015019 Open source Revenue: 45274362 Open source
19951995-12-31	Operating margin	3.5%	Operating Income: 1733645 Open source Revenue: 49623526 Open source
19961996-12-31	Operating margin	-43.2%	Operating Income: -18959590 Open source Revenue: 43855014 Open source
19971997-12-31	Operating margin	-36.2%	Operating Income: -16042202 Open source Revenue: 44296444 Open source
19981998-12-31	Operating margin	-12.1%	Operating Income: -6037085 Open source Revenue: 49759285 Open source
19991999-12-31	Operating margin	-94.5%	Operating Income: -47470665 Open source Revenue: 50219878 Open source
20002000-12-31	Operating margin	7.2%	Operating Income: 6008727 Open source Revenue: 83465371 Open source
19931993-12-31	Net margin	4%	Net Income: 1215086 Open source Revenue: 30293239 Open source
19941994-12-31	Net margin	21.1%	Net Income: 9550867 Open source Revenue: 45274362 Open source
19951995-12-31	Net margin	-2%	Net Income: -990948 Open source Revenue: 49623526 Open source
19961996-12-31	Net margin	-56.3%	Net Income: -24711036 Open source Revenue: 43855014 Open source
19971997-12-31	Net margin	-39.4%	Net Income: -17441316 Open source Revenue: 44296444 Open source
19981998-12-31	Net margin	-16.9%	Net Income: -8396493 Open source Revenue: 49759285 Open source
19991999-12-31	Net margin	-101.6%	Net Income: -51022524 Open source Revenue: 50219878 Open source
20002000-12-31	Net margin	0.8%	Net Income: 676437 Open source Revenue: 83465371 Open source
19931993-12-31	Free cash flow margin	-0.5%	Revenue: 30293239 Open source Operating Cash Flow: 980463 Open source Capital Expenditure: 1145677 Open source
19941994-12-31	Free cash flow margin	-6.4%	Revenue: 45274362 Open source Operating Cash Flow: 3256646 Open source Capital Expenditure: 6165584 Open source
19951995-12-31	Free cash flow margin	-22.7%	Revenue: 49623526 Open source Operating Cash Flow: -6023456 Open source Capital Expenditure: 5248610 Open source
19961996-12-31	Free cash flow margin	-38.9%	Revenue: 43855014 Open source Operating Cash Flow: -11812211 Open source Capital Expenditure: 5244306 Open source
19971997-12-31	Free cash flow margin	-35.7%	Revenue: 44296444 Open source Operating Cash Flow: -14350292 Open source Capital Expenditure: 1473658 Open source
19981998-12-31	Free cash flow margin	-35.1%	Revenue: 49759285 Open source Operating Cash Flow: -16147921 Open source Capital Expenditure: 1311698 Open source
19991999-12-31	Free cash flow margin	-79.8%	Revenue: 50219878 Open source Operating Cash Flow: -34678044 Open source Capital Expenditure: 5385363 Open source
20002000-12-31	Free cash flow margin	-22%	Revenue: 83465371 Open source Operating Cash Flow: -16840184 Open source Capital Expenditure: 1532188 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -16.8M 2000

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Operating cash flow	980463	Operating Cash Flow: 980463 Open source
19941994-12-31	Operating cash flow	3256646	Operating Cash Flow: 3256646 Open source
19951995-12-31	Operating cash flow	-6023456	Operating Cash Flow: -6023456 Open source
19961996-12-31	Operating cash flow	-11812211	Operating Cash Flow: -11812211 Open source
19971997-12-31	Operating cash flow	-14350292	Operating Cash Flow: -14350292 Open source
19981998-12-31	Operating cash flow	-16147921	Operating Cash Flow: -16147921 Open source
19991999-12-31	Operating cash flow	-34678044	Operating Cash Flow: -34678044 Open source
20002000-12-31	Operating cash flow	-16840184	Operating Cash Flow: -16840184 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -18.4M 2000

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19931993-12-31	Free cash flow	-165214	Operating Cash Flow: 980463 Open source Capital Expenditure: 1145677 Open source
19941994-12-31	Free cash flow	-2908938	Operating Cash Flow: 3256646 Open source Capital Expenditure: 6165584 Open source
19951995-12-31	Free cash flow	-11272066	Operating Cash Flow: -6023456 Open source Capital Expenditure: 5248610 Open source
19961996-12-31	Free cash flow	-17056517	Operating Cash Flow: -11812211 Open source Capital Expenditure: 5244306 Open source
19971997-12-31	Free cash flow	-15823950	Operating Cash Flow: -14350292 Open source Capital Expenditure: 1473658 Open source
19981998-12-31	Free cash flow	-17459619	Operating Cash Flow: -16147921 Open source Capital Expenditure: 1311698 Open source
19991999-12-31	Free cash flow	-40063407	Operating Cash Flow: -34678044 Open source Capital Expenditure: 5385363 Open source
20002000-12-31	Free cash flow	-18372372	Operating Cash Flow: -16840184 Open source Capital Expenditure: 1532188 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

82.2% 2000

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Liabilities / assets	Not reported	No source recorded
19941994-12-31	Liabilities / assets	103.3%	Total Liabilities: 38232740 Open source Total Assets: 37001840 Open source
19951995-12-31	Liabilities / assets	80.3%	Total Liabilities: 36278989 Open source Total Assets: 45177311 Open source
19961996-12-31	Liabilities / assets	48.5%	Total Liabilities: 25994633 Open source Total Assets: 53633856 Open source
19971997-12-31	Liabilities / assets	58%	Total Liabilities: 29090254 Open source Total Assets: 50125941 Open source
19981998-12-31	Liabilities / assets	60.5%	Total Liabilities: 37148546 Open source Total Assets: 61424350 Open source
19991999-12-31	Liabilities / assets	96.8%	Total Liabilities: 78183318 Open source Total Assets: 80773417 Open source
20002000-12-31	Liabilities / assets	82.2%	Total Liabilities: 67409059 Open source Total Assets: 81965696 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.93× 2000

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1993-12-31	Current assets / current liabilities	Not reported	No source recorded
19941994-12-31	Current assets / current liabilities	0.87×	Current Assets: 17457261 Open source Current Liabilities: 19965322 Open source
19951995-12-31	Current assets / current liabilities	1.28×	Current Assets: 21042550 Open source Current Liabilities: 16441532 Open source
19961996-12-31	Current assets / current liabilities	1.69×	Current Assets: 23915512 Open source Current Liabilities: 14116414 Open source
19971997-12-31	Current assets / current liabilities	1.24×	Current Assets: 21198178 Open source Current Liabilities: 17081185 Open source
19981998-12-31	Current assets / current liabilities	2.35×	Current Assets: 32924481 Open source Current Liabilities: 13988506 Open source
19991999-12-31	Current assets / current liabilities	1.06×	Current Assets: 49206692 Open source Current Liabilities: 46627534 Open source
20002000-12-31	Current assets / current liabilities	1.93×	Current Assets: 51427487 Open source Current Liabilities: 26661344 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1993 1993-01-01 – 1993-12-31	USD 1.22 million Exact value Exact value: 1215086 USD 1993-01-01 – 1993-12-31: 1215086 USD Inspect Net Income Open source Share or cite Citation for Net Income · DURAMED PHARMACEUTICALS INC · 1993-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Net Income: 1215086 USD Concept: fundies:NetIncome Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ANetIncome&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1215086 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-96-001904.txt#2033 The citation records this snapshot. The page link may show a newer release later.	USD 980,463 Exact value Exact value: 980463 USD 1993-01-01 – 1993-12-31: 980463 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DURAMED PHARMACEUTICALS INC · 1993-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Operating Cash Flow: 980463 USD Concept: fundies:OperatingCashFlow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3AOperatingCashFlow&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 980463 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-96-001904.txt#2053 The citation records this snapshot. The page link may show a newer release later.	USD 1.15 million Exact value Exact value: 1145677 USD 1993-01-01 – 1993-12-31: 1145677 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DURAMED PHARMACEUTICALS INC · 1993-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Capital Expenditure: 1145677 USD Concept: fundies:CapitalExpenditure Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ACapitalExpenditure&period=1993-12-31&surface=latest&period_type=duration&start=1993-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1145677 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-96-001904.txt#2057 The citation records this snapshot. The page link may show a newer release later.	−USD 165,214 Calculation and evidence 980463 − 1145677 USD Exact free cash flow: -165214 USD 1993-01-01 – 1993-12-31: 980463 USD · Inspect Operating Cash Flow · Source 1993-01-01 – 1993-12-31: 1145677 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DURAMED PHARMACEUTICALS INC · 1993-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Free cash flow: -165214 USD Concept: free-cash-flow Period: 1993-01-01 to 1993-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 980463 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-96-001904.txt#2053 Input fundies:CapitalExpenditure: 1145677 USD (1993-01-01 to 1993-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-96-001904.txt#2057 The citation records this snapshot. The page link may show a newer release later.
1994 1994-01-01 – 1994-12-31	USD 9.55 million Exact value Exact value: 9550867 USD 1994-01-01 – 1994-12-31: 9550867 USD Inspect Net Income Open source Share or cite Citation for Net Income · DURAMED PHARMACEUTICALS INC · 1994-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Net Income: 9550867 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9550867 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-97-006128.txt#2434 The citation records this snapshot. The page link may show a newer release later.	USD 3.26 million Exact value Exact value: 3256646 USD 1994-01-01 – 1994-12-31: 3256646 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DURAMED PHARMACEUTICALS INC · 1994-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Operating Cash Flow: 3256646 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3256646 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-97-006128.txt#2453 The citation records this snapshot. The page link may show a newer release later.	USD 6.17 million Exact value Exact value: 6165584 USD 1994-01-01 – 1994-12-31: 6165584 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DURAMED PHARMACEUTICALS INC · 1994-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Capital Expenditure: 6165584 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6165584 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-97-006128.txt#2457 The citation records this snapshot. The page link may show a newer release later.	−USD 2.91 million Calculation and evidence 3256646 − 6165584 USD Exact free cash flow: -2908938 USD 1994-01-01 – 1994-12-31: 3256646 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 6165584 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DURAMED PHARMACEUTICALS INC · 1994-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Free cash flow: -2908938 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3256646 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-97-006128.txt#2453 Input fundies:CapitalExpenditure: 6165584 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-97-006128.txt#2457 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 990,948 Exact value Exact value: -990948 USD 1995-01-01 – 1995-12-31: -990948 USD Inspect Net Income Open source Share or cite Citation for Net Income · DURAMED PHARMACEUTICALS INC · 1995-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Net Income: -990948 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -990948 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-98-002891.txt#2699 The citation records this snapshot. The page link may show a newer release later.	−USD 6.02 million Exact value Exact value: -6023456 USD 1995-01-01 – 1995-12-31: -6023456 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DURAMED PHARMACEUTICALS INC · 1995-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Operating Cash Flow: -6023456 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6023456 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-98-002891.txt#2719 The citation records this snapshot. The page link may show a newer release later.	USD 5.25 million Exact value Exact value: 5248610 USD 1995-01-01 – 1995-12-31: 5248610 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DURAMED PHARMACEUTICALS INC · 1995-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Capital Expenditure: 5248610 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5248610 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-98-002891.txt#2723 The citation records this snapshot. The page link may show a newer release later.	−USD 11.27 million Calculation and evidence -6023456 − 5248610 USD Exact free cash flow: -11272066 USD 1995-01-01 – 1995-12-31: -6023456 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 5248610 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DURAMED PHARMACEUTICALS INC · 1995-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Free cash flow: -11272066 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6023456 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-98-002891.txt#2719 Input fundies:CapitalExpenditure: 5248610 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-98-002891.txt#2723 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 24.71 million Exact value Exact value: -24711036 USD 1996-01-01 – 1996-12-31: -24711036 USD Inspect Net Income Open source Share or cite Citation for Net Income · DURAMED PHARMACEUTICALS INC · 1996-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Net Income: -24711036 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24711036 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-99-007516.txt#3144 The citation records this snapshot. The page link may show a newer release later.	−USD 11.81 million Exact value Exact value: -11812211 USD 1996-01-01 – 1996-12-31: -11812211 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DURAMED PHARMACEUTICALS INC · 1996-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Operating Cash Flow: -11812211 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11812211 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-99-007516.txt#3164 The citation records this snapshot. The page link may show a newer release later.	USD 5.24 million Exact value Exact value: 5244306 USD 1996-01-01 – 1996-12-31: 5244306 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DURAMED PHARMACEUTICALS INC · 1996-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Capital Expenditure: 5244306 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5244306 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-99-007516.txt#3168 The citation records this snapshot. The page link may show a newer release later.	−USD 17.06 million Calculation and evidence -11812211 − 5244306 USD Exact free cash flow: -17056517 USD 1996-01-01 – 1996-12-31: -11812211 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 5244306 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DURAMED PHARMACEUTICALS INC · 1996-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Free cash flow: -17056517 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11812211 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-99-007516.txt#3164 Input fundies:CapitalExpenditure: 5244306 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-99-007516.txt#3168 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 17.44 million Exact value Exact value: -17441316 USD 1997-01-01 – 1997-12-31: -17441316 USD Inspect Net Income Open source Share or cite Citation for Net Income · DURAMED PHARMACEUTICALS INC · 1997-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Net Income: -17441316 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17441316 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-00-002580.txt#2937 The citation records this snapshot. The page link may show a newer release later.	−USD 14.35 million Exact value Exact value: -14350292 USD 1997-01-01 – 1997-12-31: -14350292 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DURAMED PHARMACEUTICALS INC · 1997-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Operating Cash Flow: -14350292 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14350292 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-00-002580.txt#2954 The citation records this snapshot. The page link may show a newer release later.	USD 1.47 million Exact value Exact value: 1473658 USD 1997-01-01 – 1997-12-31: 1473658 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DURAMED PHARMACEUTICALS INC · 1997-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Capital Expenditure: 1473658 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1473658 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-00-002580.txt#2958 The citation records this snapshot. The page link may show a newer release later.	−USD 15.82 million Calculation and evidence -14350292 − 1473658 USD Exact free cash flow: -15823950 USD 1997-01-01 – 1997-12-31: -14350292 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 1473658 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DURAMED PHARMACEUTICALS INC · 1997-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Free cash flow: -15823950 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14350292 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-00-002580.txt#2954 Input fundies:CapitalExpenditure: 1473658 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-00-002580.txt#2958 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 8.4 million Exact value Exact value: -8396493 USD 1998-01-01 – 1998-12-31: -8396493 USD Inspect Net Income Open source Share or cite Citation for Net Income · DURAMED PHARMACEUTICALS INC · 1998-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Net Income: -8396493 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8396493 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2349 The citation records this snapshot. The page link may show a newer release later.	−USD 16.15 million Exact value Exact value: -16147921 USD 1998-01-01 – 1998-12-31: -16147921 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DURAMED PHARMACEUTICALS INC · 1998-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Operating Cash Flow: -16147921 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16147921 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2366 The citation records this snapshot. The page link may show a newer release later.	USD 1.31 million Exact value Exact value: 1311698 USD 1998-01-01 – 1998-12-31: 1311698 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DURAMED PHARMACEUTICALS INC · 1998-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Capital Expenditure: 1311698 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1311698 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2370 The citation records this snapshot. The page link may show a newer release later.	−USD 17.46 million Calculation and evidence -16147921 − 1311698 USD Exact free cash flow: -17459619 USD 1998-01-01 – 1998-12-31: -16147921 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 1311698 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DURAMED PHARMACEUTICALS INC · 1998-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Free cash flow: -17459619 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16147921 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2366 Input fundies:CapitalExpenditure: 1311698 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2370 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 51.02 million Exact value Exact value: -51022524 USD 1999-01-01 – 1999-12-31: -51022524 USD Inspect Net Income Open source Share or cite Citation for Net Income · DURAMED PHARMACEUTICALS INC · 1999-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Net Income: -51022524 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51022524 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2349 The citation records this snapshot. The page link may show a newer release later.	−USD 34.68 million Exact value Exact value: -34678044 USD 1999-01-01 – 1999-12-31: -34678044 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DURAMED PHARMACEUTICALS INC · 1999-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Operating Cash Flow: -34678044 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34678044 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2366 The citation records this snapshot. The page link may show a newer release later.	USD 5.39 million Exact value Exact value: 5385363 USD 1999-01-01 – 1999-12-31: 5385363 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DURAMED PHARMACEUTICALS INC · 1999-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Capital Expenditure: 5385363 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5385363 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2370 The citation records this snapshot. The page link may show a newer release later.	−USD 40.06 million Calculation and evidence -34678044 − 5385363 USD Exact free cash flow: -40063407 USD 1999-01-01 – 1999-12-31: -34678044 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 5385363 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DURAMED PHARMACEUTICALS INC · 1999-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Free cash flow: -40063407 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -34678044 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2366 Input fundies:CapitalExpenditure: 5385363 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2370 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	USD 676,437 Exact value Exact value: 676437 USD 2000-01-01 – 2000-12-31: 676437 USD Inspect Net Income Open source Share or cite Citation for Net Income · DURAMED PHARMACEUTICALS INC · 2000-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Net Income: 676437 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: 676437 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2349 The citation records this snapshot. The page link may show a newer release later.	−USD 16.84 million Exact value Exact value: -16840184 USD 2000-01-01 – 2000-12-31: -16840184 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DURAMED PHARMACEUTICALS INC · 2000-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Operating Cash Flow: -16840184 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16840184 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2366 The citation records this snapshot. The page link may show a newer release later.	USD 1.53 million Exact value Exact value: 1532188 USD 2000-01-01 – 2000-12-31: 1532188 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DURAMED PHARMACEUTICALS INC · 2000-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Capital Expenditure: 1532188 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1532188 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2370 The citation records this snapshot. The page link may show a newer release later.	−USD 18.37 million Calculation and evidence -16840184 − 1532188 USD Exact free cash flow: -18372372 USD 2000-01-01 – 2000-12-31: -16840184 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 1532188 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DURAMED PHARMACEUTICALS INC · 2000-12-31 DURAMED PHARMACEUTICALS INC (edgar:799903) Free cash flow: -18372372 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T22:00:11Z Snapshot: 6f209a235c310e7c1b10697e8f71c9c60f4428ca53d716e01dffb48806169c81 Dimensions: Consolidated View: https://fundies.io/companies/edgar/799903?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16840184 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2366 Input fundies:CapitalExpenditure: 1532188 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/799903/0000950152-01-001390.txt#2370 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

37 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000799903, 799903, edgar:799903

DURAMED PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2000 2000-01-01 – 2000-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation